Spotlight on second medical use claims
Claims directed to new therapeutic uses of known compounds, so-called second medical use claims, have been accepted by the European Patent Office for over 30 years. It has been widely recognised that the granting of second medical use patents incentivises important medical research. However, a great deal of uncertainty surrounds the enforcement of such patents, which creates problems for pharmaceutical companies and generics manufacturers alike.
CPC4 Capital Park
Salisbury Square House
8 Salisbury Square